Related Experiment Video
Updated: Sep 26, 2026

Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
Dopaminergic sensitization of rats with and without early prefrontal lesions: implications for the pathogenesis of
Birte Y. Glenthøj1, Jesper Mogensen, Henning Laursen
1Department of Psychiatry, University of Copenhagen, Copenhagen, Bispebjerg Hospital, DK-2400, Denmark.
Abstract:
To study whether an early lesion of prefrontal cortex (PFC) would influence mesolimbic dopaminergic sensitization induced by intermittent electrical stimulation (IES) of the ventral tegmental area (VTA) or change social interactions in animals exposed to both electrical sensitization and prefrontal lesions, we examined the behaviour of rats with or without early prefrontal lesions following repeated electrical stimulation of the VTA. Additionally, we wanted to study the influence of immobilization stress on rats exposed to a combination of prefrontal lesion and daily restraint in Plexiglas tubes prior to IES. Neither early lesion of PFC nor repeated restraint influenced development of sensitization. However, the combination of early prefrontal lesion and IES resulted in changes in social interactions neither seen following IES nor in lesioned rats. The changes were most pronounced in the group exposed to both IES, prefrontal lesions and restraint. Furthermore, repeated restraint caused a significant increase in the threshold current for provocation of the behavioural response related to VTA stimulation (head stereotypies/sniffing). The implications of the findings for sensitization of the mesolimbic dopaminergic system as a model for development of schizophrenia are discussed.
Related Concept Videos
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Parkinson Disease ll: Pathophysiology

